| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Bone and Mineral Research Unit, Veterans Affairs Medical Center, (K.M.W., X.Z., E.S.O.) Portland, Oregon 97201; the Departments of Behavioral Neuroscience (K.M.W.), Cell and Developmental Biology (K.M.W.), Medicine (K.M.W. and E.S.O.), Pharmacology (E.K.), and Surgery (E.K.), Oregon Health Sciences University, Portland, Oregon 97201; and the Department of Medicine, Comprehensive Cancer Center and Endocrinology-Reproductive Physiology Program, University of Wisconsin (C.C.), Madison, Wisconsin 53792
Address all correspondence and requests for reprints to: Kristine Wiren, Ph.D., Research Service 151Q, Veterans Administration Medical Center, 3710 SW Veterans Hospital Road, Portland, Oregon 97201. E-mail: wirenk{at}teleport.com
Androgen regulation of androgen receptor (AR) expression has been observed in a variety of tissues, generally as inhibition, and is thought to attenuate cellular responses to androgen. AR is expressed in osteoblasts, the bone-forming cell, suggesting direct actions of androgens on bone. Here we characterized the effect of androgen exposure on AR gene expression in human osteoblastic SaOS-2 and U-2 OS cells.
Treatment of osteoblastic cells with the nonaromatizable androgen
5
-dihydrotestosterone increased AR steady state messenger RNA levels
in a time- and dose-dependent fashion. Reporter assays with 2.3
kilobases of the proximal 5'-flanking region of the human AR promoter
linked to the chloramphenicol acetyltransferase gene in transfected
cultures showed that up-regulation of AR promoter activity by androgen
was time and dose dependent. Treatment with other steroid hormones,
including progesterone, 17ß-estradiol, and dexamethasone, was without
effect. The antiandrogen hydroxyflutamide completely antagonized
androgen up-regulation.
Thus, in contrast to many other androgen target tissues, androgen exposure increases steady state AR messenger RNA levels in osteoblasts. This regulation occurs at least partially at the level of transcription, is mediated by the 5'-promoter region of the AR gene, and is dependent on functional AR. These results suggest that physiological concentrations of androgens have significant effects on AR expression in skeletal tissue.
This article has been cited by other articles:
![]() |
S. Seenundun and B. Robaire Time-Dependent Rescue of Gene Expression by Androgens in the Mouse Proximal Caput Epididymidis-1 Cell Line after Androgen Withdrawal Endocrinology, January 1, 2007; 148(1): 173 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Lee and C. Chang Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Issa, D. Schnabel, M. Feix, L. Wolf, H.-E. Schaefer, D. W. Russell, and H.-U. Schweikert Human Osteoblast-Like Cells Express Predominantly Steroid 5{alpha}-Reductase Type 1 J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5401 - 5407. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Barbulescu, C. Geserick, I. Schuttke, W.-D. Schleuning, and B. Haendler New Androgen Response Elements in the Murine Pem Promoter Mediate Selective Transactivation Mol. Endocrinol., October 1, 2001; 15(10): 1803 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grad, L. S. Lyons, D. M. Robins, and K. L. Burnstein The Androgen Receptor (AR) Amino-Terminus Imposes Androgen-Specific Regulation of AR Gene Expression via an Exonic Enhancer Endocrinology, March 1, 2001; 142(3): 1107 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grad, J. Le Dai, S. Wu, and K. L. Burnstein Multiple Androgen Response Elements and a Myc Consensus Site in the Androgen Receptor (AR) Coding Region Are Involved in Androgen-Mediated Up-Regulation of AR Messenger RNA Mol. Endocrinol., November 1, 1999; 13(11): 1896 - 1911. [Abstract] [Full Text] |
||||
![]() |
C. S. Song, M. H. Jung, P. C. Supakar, B. Chatterjee, and A. K. Roy Negative Regulation of the Androgen Receptor Gene Promoter by NFI and an Adjacently Located Multiprotein-Binding Site Mol. Endocrinol., September 1, 1999; 13(9): 1487 - 1496. [Abstract] [Full Text] |
||||
![]() |
K. Wiren, E. Keenan, X. Zhang, B. Ramsey, and E. Orwoll Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness Endocrinology, July 1, 1999; 140(7): 3114 - 3124. [Abstract] [Full Text] |
||||
![]() |
B. B. Yeap, R. G. Krueger, and P. J. Leedman Differential Posttranscriptional Regulation of Androgen Receptor Gene Expression by Androgen in Prostate and Breast Cancer Cells Endocrinology, July 1, 1999; 140(7): 3282 - 3291. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |